SNTI
Senti Biosciences Inc
NASDAQ: SNTI · HEALTHCARE · BIOTECHNOLOGY
$0.92
-5.99% today
Updated 2026-04-30
Market cap
$29.75M
P/E ratio
—
P/S ratio
1,352.38x
EPS (TTM)
$-2.73
Dividend yield
—
52W range
$1 – $4
Volume
0.2M
Senti Biosciences Inc (SNTI) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $85000.00 | $394000.00 | $2.29M | $4.29M | $1.98M | $0.00 | $22000.00 |
| Revenue growth (YoY) | — | +363.5% | +481.5% | +87.1% | -53.8% | -100.0% | — |
| Cost of revenue | $14.52M | $15.96M | $3.01M | $3.92M | $5.24M | — | $3.64M |
| Gross profit | $-14.44M | $394000.00 | $2.29M | $4.29M | $1.98M | — | $-3.62M |
| Gross margin | -16987.1% | 100.0% | 100.0% | 100.0% | 100.0% | — | -16431.8% |
| R&D | $14.52M | $15.96M | $21.96M | $34.07M | $32.15M | $34.36M | $37.59M |
| SG&A | $7.34M | $9.30M | $21.25M | $40.85M | $34.87M | $23.51M | $26.16M |
| Operating income | $-21.78M | $-24.69M | $-40.45M | $-70.63M | $-92.73M | $-61.04M | $-63.73M |
| Operating margin | -25625.9% | -6267.5% | -1765.4% | -1647.9% | -4687.9% | — | -289668.2% |
| EBITDA | $-21.36M | $-22.71M | $-37.44M | $-66.71M | $-61.34M | $-54.88M | $-60.09M |
| EBITDA margin | -25123.5% | -5763.7% | -1634.0% | -1556.4% | -3100.9% | — | -273136.4% |
| EBIT | $-21.78M | $-24.69M | $-40.45M | $-70.63M | $-66.77M | $-60.73M | $-63.73M |
| Interest expense | $0.00 | $88000.00 | $11000.00 | $3.92M | — | — | — |
| Income tax | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-21.16M | $-19.86M | $-55.32M | $-45.79M | $-71.06M | $-52.79M | $-61.44M |
| Net income growth (YoY) | — | +6.1% | -178.5% | +17.2% | -55.2% | +25.7% | -16.4% |
| Profit margin | -24890.6% | -5041.1% | -2414.6% | -1068.4% | -3592.4% | — | -279263.6% |